What type of study is this?

This is a RNA-seq study (also classified as: RT-qPCR, Flow Cytometry, Droplet digital PCR).

September 10, 2025Translational Lung Cancer ResearchOpen Access

MiR-200a regulates PD-L1 and predicts response to immune checkpoint inhibitors in advanced non-small cell lung cancer

View Full Paper

Ask AI

Bookmark

Authors

AKAyami KanekoYokohama City University Hospital NKNobuaki KobayashiNihon University SKSousuke KuboYokohama City University Medical Center

Discussion

Member takes

Implication

This analysis reveals miR-200a impacts PD-L1 in non-small cell lung cancer patients, suggesting it as a biomarker for immune checkpoint therapy efficacy.

Key Points

Low serum miR-200a levels correlate with higher tumor PD-L1 expression in advanced non-small cell lung cancer (NSCLC), impacting patient outcomes.
In vitro findings show that miR-200a mimics significantly reduce PD-L1 protein expression in lung cancer cell lines, indicating a regulatory role.
The analysis of public RNA sequencing data demonstrates a significant inverse relationship between miR-200 expression and PD-L1 levels, validating clinical relevance.
Serum miR-200a serves as a potential non-invasive biomarker and may aid in predicting response to immune checkpoint inhibitors in NSCLC patients.

Cite This Study

Kaneko et al. (2025) studied this question.

synapsesocial.com/papers/68c1a25354b1d3bfb60dccce https://doi.org/10.21037/tlcr-2025-117

View Full Paper

Ask AI

Bookmark

Implication

This analysis reveals miR-200a impacts PD-L1 in non-small cell lung cancer patients, suggesting it as a biomarker for immune checkpoint therapy efficacy.

MiR-200a regulates PD-L1 and predicts response to immune checkpoint inhibitors in advanced non-small cell lung cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

MiR-200a regulates PD-L1 and predicts response to immune checkpoint inhibitors in advanced non-small cell lung cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider